目的:了解血管生成素样蛋白(ANGPTL)3及ANGPTL4在RA患者血清中的表达情况,初步探讨ANGPTL3、ANGPTL4与RA临床表现及实验室指标的相关性。方法收集72例RA患者及28例健康体检者血清及临床资料,应用ELISA检测血清ANGPTL3、ANGPTL4、NF-κB受体活化因子配体(RANKL)水平,组间数据比较采用非参数秩和检验,两因素间关系采用Spearman相关分析。结果①RA患者血清ANGPTL3水平较对照升高[800.325(577.477,1750.636) pg/ml和487.900(382.340,565.499) pg/ml,Z=-6.082,P<0.05];RA患者血清ANGPTL4水平较对照升高[1036.199(853.347,1746.677) pg/ml和706.095(558.571,807.302) pg/ml,Z=-5.962,P<0.05];②RA患者血清ANGPTL3、ANGPTL4水平随疾病活动加重而升高[ANGPTL3:低活动组457.265(373.709,605.296) pg/ml,中活动组785.815(679.156,1308.785) pg/ml,高活动组1502.038(817.713,1960.493) pg/ml,P<0.05;ANGPTL4:低活动组737.604(467.040,918.222) pg/ml,中活动组991.227(819.456,1699.972) pg/ml,高活动组1842.310(1252.023,2669.902) pg/ml,P<0.05];③ RA患者血清ANGPTL3、ANGPTL4与RANKL呈正相关(r分别为0.554、0.619,P<0.05);④RA患者双手加腕关节X线片
作者:聂华翎;郑毅
来源:中华风湿病学杂志 2016 年 2期